Based on the company's latest reports for April 2026, the current 12-month EPS is $7.89. Waters's earnings per share in 2025 was reported at $10.8, marking a rise from $10.75 in 2024. In the quarterly report ending on Apr 4, 2026, WAT's earnings per share amounted to -$0.87.
Waters had an yealy earnings per share of $10.8, showing a rise of 0.5% from $10.75 recorded in 2024. The quarterly earnings per share for the period ending Apr 4, 2026, was -$0.87, showing a 142.6% decline compared to the same quarter last year. The trailing twelve months EPS for WAT is $7.89 as of April 2026. Waters's full-year EPS for 2024 was $10.75, a 1.1% decline compared to the previous year.
Waters has recorded a decline in earnings per share of 142.6% in the past 12 months (YoY, quarterly). During the past three years, WAT registered an average yearly EPS growth of -2.9%. Waters had an average annual EPS growth of 5.2% in the last five years. Over the last decade, WAT had an average annual earnings per share growth of 6.6%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| A Agilent Technologies Inc | 25.19 | 3.4% | 3.1% | 14.5% |
| TMO Thermo Fisher Scientific Inc | 25.52 | 7.2% | 0% | 2% |
| MTD Mettler Toledo International Inc | 27.27 | 3.7% | 2.8% | 10.8% |
| DHR Danaher Corp | 34.57 | -4.9% | -19.7% | 0.4% |
| GE General Electric Co | 42.78 | 35.8% | 447.4% | 12.1% |
| WAT Waters Corp | 45.41 | 0.5% | -2.9% | 5.2% |
| BIO Bio-Rad Laboratories Inc | 48.22 | 142.6% | N/A | -26.3% |
| BRKR Bruker Corp | N/A | -119.7% | N/A | N/A |
| HBIO Harvard Bioscience Inc | N/A | -357.1% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.